Physician profile

Caitlin Jaeckel

Philadelphia, PA

NPI 1912596644

$2,297.82

in general payments reported to CMS, 2019-2025

7 companies · $532 in 2025

The $532 reported for 2025 was more than what 80% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,105.56

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Gilead Sciences, INC. $1,057.30 2023-2025 Descovy, Epclusa, Biktarvy
Viiv Healthcare Company $605.49 2023-2025 Apretude, Dovato, Cabenuva
Abbvie INC. $292.36 2021-2025
Merck Sharp & Dohme LLC $192.13 2023-2024 Pifeltro, Delstrigo, Dificid
Braeburn INC. $100.11 2025 Brixadi
Janssen Biotech, INC. $31.61 2023 Prezcobix
Theratechnologies INC. $18.82 2023 Egrifta Sv

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Caitlin Jaeckel

$2,297.82

in general payments reported 2019-2025

Years
2021-2025
Top company
Gilead Sciences, INC.
Context
The $532 reported for 2025 was more than what 80% of providers received nationally.

https://glasscript.com/doctor/11287195/caitlin-jaeckel

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.